Abstract
Male breast cancer (MBC) is a relatively rare disease, accounting for <1% of all breast cancers in the western world and 0.1% of cancer deaths in men . The causes are still poorly understood and the low incidence of MBC means that studies are small and underpowered. The treatment of MBC is based on large trials in postmenopausal women. The outlook for men is the same as women stage for stage, but overall the prognosis tends to be poorer. This is usually due to a delay in presentation – despite increasing awareness of MBC, there remains an average delay from the onset of symptoms to diagnosis of 6–10 months, with little improvement in survival over the last 25 years.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Nat Cancer Inst. 2003;95:1276–99.
Joshi MG, Lee AK, Loda M, et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer. 1996;77:490–8.
O’Malley CD, Prehn AW, Shema SJ, et al. Racial/ethnic differences in survival rates in a population based series of men with breast cancer. Cancer. 2002;94:2836–42.
Sheik O. Male breast cancer: factors influencing prognosis. Br J Cancer. 1975;30:13–35.
Hodgson NC, Button JH, Franceschi D, et al. Male breast cancer: is the incidence increasing? Ann Surg Oncol. 2004;2010(8):751–5.
Mabuchi K, Bross DS, Kessler II. Risk factors for male breast cancer. J Natl Cancer Inst. 1985;74:371–5.
Ojara EA. Carcinoma of the male breast in Mulago Hospital, Kampala. East Afr Med J. 1978;55:489–91.
Bhagwandin S. Carcinoma of the male breast in Zambia. East Afr Med J. 1972;49:176–9.
Waterhouse J, Muir C, Correa P, et al. Cancer incidence in five continents, vol 3. IARC Sci Publ 1976;(15):1–583.
Anderson WF, Althius MD, Brinton LA, et al. Is male breast cancer similar or different from female breast cancer? Br Cancer Res Treat. 2004;83:77–86.
Basham VM, Lipscombe JM, Ward JM, et al. BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res. 2002;4(1):R2.
Friedman LS, Gayther SA, Kurosaki T, et al. Mutation analysis of BRCA1 and BRCA2 mutations in a male breast cancer population. Am J Hum Genet. 1997;60:313–9.
Fackenthal JD, Marsh DJ, Richardson AL, et al. Male breast cancer in Cowden syndrome patients with germline PTEN mutations. J Med Genet. 2001;38:159–64.
Harnden DG, Maclean N, Langlands AO. Carcinoma of the breast and Klinefelter’s syndrome. J Med Genet. 1971;8:460–1.
Price WH, Clayton JF, Wilson J, Collyer S, De Mey R. Causes of death in X chromatin positive males (Klinefelter’s syndrome). J Epidemiol Community Health. 1985;39:330–6.
McLaughlin JK, Malker BR, Blot WJ, et al. Occupational risks for male breast cancer in Sweden. Br J Indust Med. 1988;4:275–6.
Hansen J. Elevated risk for male breast cancer after exposure to gasoline and vehicular combustion products. Am J Ind Med. 2000;37:349–52.
Loomis DP. Cancer of breast among men in electrical occupations. Lancet. 1992;339:1482–3.
Lenfant-Pejovic M-H, Mlika-Cabanne N, Bouchardy C, et al. Risk factors for male breast cancer: a Franco-Swiss case-control study. Int J Cancer. 1990;45:661–5.
Olsson H, Ranstam J. Head trauma and exposure to Prolactin-elevating drugs as risk factors for male breast cancer. J Natl Cancer Inst. 1988;80:679–83.
Sasco AJ, Lowenfels AB, Pasker de Jong P. Epidemiology of male breast cancer: a meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer. 1993;53:539–49.
Ron E, Ikeda T, Preston DL, et al. Male breast cancer incidence among atomic bomb survivors. J Natl Cancer Inst. 2005;97:603–5.
McClure JA, Higgins CC. Bilateral carcinoma of male breast after estrogen therapy. JAMA. 1951;146:7–9.
Symmers WSC. Carcinoma of the breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sexual characteristics. Br Med J. 1968;2:83–5.
Thomas DB, Jimenez LM, McTiernan A, et al. Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol. 1992;135:734–48.
Johnson KC, Pan S, Mao Y. Risk factors for male breast cancer in Canada, 1994-1998. Eur J Cancer Prev. 2002;2010:253–63.
Hsing AW, McLaughlin JK, Cocco P, et al. Risk factors for male breast cancer (United States). Cancer Causes Control. 1998;9:269–76.
Guenel P, Cyr D, Sabroe S, et al. Alcohol drinking may increase the risk of breast cancer in men: a European population-based case-control study. Cancer Causes Control. 2004;15:571–80.
Volm MD, Talamonti MS, Thangavelu M, et al. Pituitary adenoma and bilateral male breast cancer: an unusual association. J Surg Oncol. 1997;64:74–8.
Ribeiro GG, Swindell R, Harris M, et al. A review of the management of the male breast carcinoma based on an analysis of 420 treated cases. Breast. 1996;5:141–6.
van Geel AN, van Slooten EA, Mavrunac M, et al. A retrospective study of male breast cancer in Holland. Br J Surg. 1985;72:724–7.
Goss PE, Reid C, Pintilie M, et al. Male breast carcinoma: a review of 229 cases who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer. 1999;85:629–39.
Scheike O. Male breast cancer. Acta Pathol Microbiol Scand. 1975;S251:3–35.
Ramantanis G, Besbeas S, Garas JG, et al. Breast cancer in the male: a report of 138 cases. World J Surg. 1980;4:621–4.
Stewart RAL, Howlett DC, Hearn FJ. Pictorial review: the imaging features of male breast disease. Clin Radiol. 1997;52:739–44.
Donegan WL, Redlich PN, Lang PJ, Gall MT. Carcinoma of the breast in males. Cancer. 1998;83:498–509.
Stalsberg H, Thomas DB, Rosenblatt KA, et al. Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men. Cancer Causes Control. 1993;4:143–51.
Giordano SH, Cohen DS, Buzdar AU, et al. Breast carcinoma in men: a population based study. Cancer. 2004;101:51–7.
Michaels BM, Nunn CR, Roses DF. Lobular carcinoma of the male breast. Surgery. 1994;20105:402–5.
Rayson D, Erlichman C, Suman VJ, et al. Molecular markers in male breast carcinoma. Cancer. 1998;83:2139–49.
Meijer-van Gelder ME, Look MP, Bolt-de Vries J, et al. Clinical relevance of biologic factors in male breast cancer. Breast Cancer Res Treat. 2001;68:249–60.
Bloom KJ, Govil H, Gattuso P, et al. Status of HER-2 in male and female breast carcinomas. Am J Surg. 2001;82:389–92.
Scott-Connor CE, Jochimsen PR, Menck HR, et al. An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery. 1999;126:775–80.
France L, Michie S, Barrett-Lee P, et al. Male breast cancer: a qualitative study of male breast cancer. Breast. 2000;9:342–8.
Spear SL, Bowen DG. Breast reconstruction in a male with a transverse rectus abdominis flap. Plast Reconstr Surg. 1998;102:1615–7.
Albo D, Ames FC, Hunt KK, et al. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy. Breast Cancer Res Treat. 2003;77:9–14.
Ribeiro G, Swindell R. Adjuvant tamoxifen for male breast cancer. Br J Cancer. 1992;65:252–4.
Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet. 2006;367:595–604.
Cutuli B, Lacroze M, Dilhuydy JM, et al. Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer. 1995;31A:1960–4.
Erlichman C, Murphy KC, Elhakim T. Male breast cancer: a 13 year review of 89 patients. J Clin Oncol. 1984;2:903–9.
Giordano SH, Perkins GH, Broglio K, et al. Adjuvant systemic therapy for male breast cancer. Cancer. 2005;104:235–64.
Yildirim E, Berberoglu U. Male breast cancer: a 22 year experience. Eur J Surg Oncol. 1998;24:548–52.
Jaiyesimi IA, Buzdar AU, Sahin AA, et al. Carcinoma of the male breast. Ann Internal Med. 1992;20107:771–7.
Irvine T, Fentiman S. Male breast cancer. CML Breast Cancer. 2007;19(1):1–6.
Guinee VF, Olsson H, Moller T, Shallenberger RC, van den Blink JW, et al. The prognosis of breast cancer in males. A report of 335 cases. Cancer. 1993;71(1):154–61.
NCCN clinical practice guidelins in Oncology ™ genetic/familial high-risk assessment: breast and ovarian. V.I. 2008. (http://www.nccn.org/professionals/physician_gls/PDF/genetics_screening.pdf).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer New York
About this chapter
Cite this chapter
Irvine, T., Fentiman, I.S. (2010). Male Breast Cancer. In: Dirbas, F., Scott-Conner, C. (eds) Breast Surgical Techniques and Interdisciplinary Management. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6076-4_46
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6076-4_46
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6075-7
Online ISBN: 978-1-4419-6076-4
eBook Packages: MedicineMedicine (R0)